APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pediatric CAR T-cell Therapy

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pediatric CAR T-cell Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

3 May 2026186 pages

Choose your research edition.

Industry ResearchPediatric CAR T-cell Therapy Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Pediatric CAR T-cell Therapy Industry Growth and Trends Forecast to 203288 pages · $3,450 USDMarket StructureGlobal Pediatric CAR T-cell Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pediatric CAR T-cell Therapy Market Outlook and Growth Opportunities 2026186 pages · $4,250 USDMarket Analysis & ForecastGlobal Pediatric CAR T-cell Therapy Market Analysis and Forecast 2026-2032238 pages · $4,950 USD

Market perspective

The global Pediatric CAR T-cell Therapy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Pediatric CAR T-cell Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pediatric CAR T-cell Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pediatric CAR T-cell Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pediatric CAR T-cell Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pediatric CAR T-cell Therapy include Bristol Myers Squibb，BMS, Johnson & Johnson, Gilead Sciences, Novartis, JW Therapeutics, Imunopharm Technology Co., Ltd., CARsgen Therapeutics and Cartesian Therapeutics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Pediatric CAR T-cell Therapy market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pediatric CAR T-cell Therapy and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pediatric CAR T-cell Therapy revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Pediatric CAR T-cell Therapy market size, projected growth trends, production technologies, key applications, and end-use industries.

Pediatric CAR T-cell Therapy Segment by Company

Bristol Myers Squibb，BMS

Johnson & Johnson

Gilead Sciences

Novartis

JW Therapeutics

Imunopharm Technology Co., Ltd.

CARsgen Therapeutics

Cartesian Therapeutics

Pediatric CAR T-cell Therapy Segment by Type

CD19

BCMA

Others

Pediatric CAR T-cell Therapy Segment by Application

Multiple Myeloma

B-Cell Lymphoma (BCL)

Acute Lymphoblastic Leukemia (ALL)

Others

Pediatric CAR T-cell Therapy Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pediatric CAR T-cell Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pediatric CAR T-cell Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pediatric CAR T-cell Therapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Pediatric CAR T-cell Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pediatric CAR T-cell Therapy industry.

Chapter 3: Detailed analysis of Pediatric CAR T-cell Therapy companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pediatric CAR T-cell Therapyrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pediatric CAR T-cell Therapy Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of CD19 Table 3. Key Players of BCMA Table 4. Key Players of Others Table 4. Global Pediatric CAR T-cell Therapy Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Multiple Myeloma Table 6. Key Players of B-Cell Lymphoma (BCL) Table 7. Key Players of Acute Lymphoblastic Leukemia (ALL) Table 8. Key Players of Others Table 9. Global Pediatric CAR T-cell Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Pediatric CAR T-cell Therapy Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Pediatric CAR T-cell Therapy Market Share by Region (2021-2026) Table 12. Global Pediatric CAR T-cell Therapy Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Pediatric CAR T-cell Therapy Market Share by Region (2027-2032) Table 14. Pediatric CAR T-cell Therapy Industry Trends Table 15. Pediatric CAR T-cell Therapy Industry Drivers Table 16. Pediatric CAR T-cell Therapy Industry Opportunities and Challenges Table 17. Pediatric CAR T-cell Therapy Industry Restraints Table 18. Global Pediatric CAR T-cell Therapy Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Pediatric CAR T-cell Therapy Revenue Market Share by Company (2021-2026) Table 20. Global Pediatric CAR T-cell Therapy Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Pediatric CAR T-cell Therapy Key Company Head Office and Area Served Table 22. Global Pediatric CAR T-cell Therapy Company, Product Type & Application Table 23. Global Pediatric CAR T-cell Therapy Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Pediatric CAR T-cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Pediatric CAR T-cell Therapy Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Pediatric CAR T-cell Therapy Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Pediatric CAR T-cell Therapy Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Pediatric CAR T-cell Therapy Revenue Market Share by Type (2021-2026) Table 30. Global Pediatric CAR T-cell Therapy Revenue Market Share by Type (2027-2032) Table 31. Global Pediatric CAR T-cell Therapy Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Pediatric CAR T-cell Therapy Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Pediatric CAR T-cell Therapy Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Pediatric CAR T-cell Therapy Revenue Market Share by Application (2021-2026) Table 35. Global Pediatric CAR T-cell Therapy Revenue Market Share by Application (2027-2032) Table 36. Bristol Myers Squibb，BMS Company Information Table 37. Bristol Myers Squibb，BMS Business Overview Table 38. Bristol Myers Squibb，BMS Pediatric CAR T-cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Bristol Myers Squibb，BMS Pediatric CAR T-cell Therapy Product Portfolio Table 40. Bristol Myers Squibb，BMS Recent Development Table 41. Johnson & Johnson Company Information Table 42. Johnson & Johnson Business Overview Table 43. Johnson & Johnson Pediatric CAR T-cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Johnson & Johnson Pediatric CAR T-cell Therapy Product Portfolio Table 45. Johnson & Johnson Recent Development Table 46. Gilead Sciences Company Information Table 47. Gilead Sciences Business Overview Table 48. Gilead Sciences Pediatric CAR T-cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Gilead Sciences Pediatric CAR T-cell Therapy Product Portfolio Table 50. Gilead Sciences Recent Development Table 51. Novartis Company Information Table 52. Novartis Business Overview Table 53. Novartis Pediatric CAR T-cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Novartis Pediatric CAR T-cell Therapy Product Portfolio Table 55. Novartis Recent Development Table 56. JW Therapeutics Company Information Table 57. JW Therapeutics Business Overview Table 58. JW Therapeutics Pediatric CAR T-cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. JW Therapeutics Pediatric CAR T-cell Therapy Product Portfolio Table 60. JW Therapeutics Recent Development Table 61. Imunopharm Technology Co., Ltd. Company Information Table 62. Imunopharm Technology Co., Ltd. Business Overview Table 63. Imunopharm Technology Co., Ltd. Pediatric CAR T-cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Imunopharm Technology Co., Ltd. Pediatric CAR T-cell Therapy Product Portfolio Table 65. Imunopharm Technology Co., Ltd. Recent Development Table 66. CARsgen Therapeutics Company Information Table 67. CARsgen Therapeutics Business Overview Table 68. CARsgen Therapeutics Pediatric CAR T-cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. CARsgen Therapeutics Pediatric CAR T-cell Therapy Product Portfolio Table 70. CARsgen Therapeutics Recent Development Table 71. Cartesian Therapeutics Company Information Table 72. Cartesian Therapeutics Business Overview Table 73. Cartesian Therapeutics Pediatric CAR T-cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Cartesian Therapeutics Pediatric CAR T-cell Therapy Product Portfolio Table 75. Cartesian Therapeutics Recent Development Table 76. North America Pediatric CAR T-cell Therapy Market Size by Type (2021-2026) & (US$ Million) Table 77. North America Pediatric CAR T-cell Therapy Market Size by Type (2027-2032) & (US$ Million) Table 78. North America Pediatric CAR T-cell Therapy Market Size by Application (2021-2026) & (US$ Million) Table 79. North America Pediatric CAR T-cell Therapy Market Size by Application (2027-2032) & (US$ Million) Table 80. North America Pediatric CAR T-cell Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 81. North America Pediatric CAR T-cell Therapy Market Size by Country (2021-2026) Table 82. North America Pediatric CAR T-cell Therapy Market Size by Country (2027-2032) Table 83. Europe Pediatric CAR T-cell Therapy Market Size by Type (2021-2026) & (US$ Million) Table 84. Europe Pediatric CAR T-cell Therapy Market Size by Type (2027-2032) & (US$ Million) Table 85. Europe Pediatric CAR T-cell Therapy Market Size by Application (2021-2026) & (US$ Million) Table 86. Europe Pediatric CAR T-cell Therapy Market Size by Application (2027-2032) & (US$ Million) Table 87. Europe Pediatric CAR T-cell Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 88. Europe Pediatric CAR T-cell Therapy Market Size by Country (2021-2026) Table 89. Europe Pediatric CAR T-cell Therapy Market Size by Country (2027-2032) Table 90. China Pediatric CAR T-cell Therapy Market Size by Type (2021-2026) & (US$ Million) Table 91. China Pediatric CAR T-cell Therapy Market Size by Type (2027-2032) & (US$ Million) Table 92. China Pediatric CAR T-cell Therapy Market Size by Application (2021-2026) & (US$ Million) Table 93. China Pediatric CAR T-cell Therapy Market Size by Application (2027-2032) & (US$ Million) Table 94. Asia Pediatric CAR T-cell Therapy Market Size by Type (2021-2026) & (US$ Million) Table 95. Asia Pediatric CAR T-cell Therapy Market Size by Type (2027-2032) & (US$ Million) Table 96. Asia Pediatric CAR T-cell Therapy Market Size by Application (2021-2026) & (US$ Million) Table 97. Asia Pediatric CAR T-cell Therapy Market Size by Application (2027-2032) & (US$ Million) Table 98. Asia Pediatric CAR T-cell Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. Asia Pediatric CAR T-cell Therapy Market Size by Country (2021-2026) Table 100. Asia Pediatric CAR T-cell Therapy Market Size by Country (2027-2032) Table 101. South America, Middle East & Africa Pediatric CAR T-cell Therapy Market Size by Type (2021-2026) & (US$ Million) Table 102. South America, Middle East & Africa Pediatric CAR T-cell Therapy Market Size by Type (2027-2032) & (US$ Million) Table 103. South America, Middle East & Africa Pediatric CAR T-cell Therapy Market Size by Application (2021-2026) & (US$ Million) Table 104. South America, Middle East & Africa Pediatric CAR T-cell Therapy Market Size by Application (2027-2032) & (US$ Million) Table 105. South America, Middle East & Africa Pediatric CAR T-cell Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 106. South America, Middle East & Africa Pediatric CAR T-cell Therapy Market Size by Country (2021-2026) Table 107. South America, Middle East & Africa Pediatric CAR T-cell Therapy Market Size by Country (2027-2032) Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources Table 111. Primary Sources List of Figures Figure 1. Pediatric CAR T-cell Therapy Product Image Figure 2. Global Pediatric CAR T-cell Therapy Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Pediatric CAR T-cell Therapy Market Share by Type: 2025 VS 2032 Figure 4. CD19 Image Figure 5. BCMA Image Figure 6. Others Image Figure 7. Global Pediatric CAR T-cell Therapy Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Pediatric CAR T-cell Therapy Market Share by Application: 2025 VS 2032 Figure 9. Multiple Myeloma Image Figure 10. B-Cell Lymphoma (BCL) Image Figure 11. Acute Lymphoblastic Leukemia (ALL) Image Figure 12. Others Image Figure 13. Global Pediatric CAR T-cell Therapy Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Pediatric CAR T-cell Therapy Market Size (2021-2032) & (US$ Million) Figure 15. Global Pediatric CAR T-cell Therapy Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Pediatric CAR T-cell Therapy Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Pediatric CAR T-cell Therapy Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Pediatric CAR T-cell Therapy Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Pediatric CAR T-cell Therapy Revenue Market Share by Type (2021-2032) Figure 22. Global Pediatric CAR T-cell Therapy Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Pediatric CAR T-cell Therapy Revenue Market Share by Application (2021-2032) Figure 24. North America Pediatric CAR T-cell Therapy Market Size (2021-2032) & (US$ Million) Figure 25. North America Pediatric CAR T-cell Therapy Market Share by Type (2021-2032) Figure 26. North America Pediatric CAR T-cell Therapy Market Share by Application (2021-2032) Figure 27. North America Pediatric CAR T-cell Therapy Market Share by Country (2021-2032) Figure 28. United States Pediatric CAR T-cell Therapy Market Size (2021-2032) & (US$ Million) Figure 29. Canada Pediatric CAR T-cell Therapy Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Pediatric CAR T-cell Therapy Market Size (2021-2032) & (US$ Million) Figure 31. Europe Pediatric CAR T-cell Therapy Market Size (2021-2032) & (US$ Million) Figure 32. Europe Pediatric CAR T-cell Therapy Market Share by Type (2021-2032) Figure 33. Europe Pediatric CAR T-cell Therapy Market Share by Application (2021-2032) Figure 34. Europe Pediatric CAR T-cell Therapy Market Share by Country (2021-2032) Figure 35. Germany Pediatric CAR T-cell Therapy Market Size (2021-2032) & (US$ Million) Figure 36. France Pediatric CAR T-cell Therapy Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Pediatric CAR T-cell Therapy Market Size (2021-2032) & (US$ Million) Figure 38. Italy Pediatric CAR T-cell Therapy Market Size (2021-2032) & (US$ Million) Figure 39. Russia Pediatric CAR T-cell Therapy Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Pediatric CAR T-cell Therapy Market Size (2021-2032) & (US$ Million) Figure 41. China Pediatric CAR T-cell Therapy Market Size (2021-2032) & (US$ Million) Figure 42. China Pediatric CAR T-cell Therapy Market Share by Type (2021-2032) Figure 43. China Pediatric CAR T-cell Therapy Market Share by Application (2021-2032) Figure 44. Asia Pediatric CAR T-cell Therapy Market Size (2021-2032) & (US$ Million) Figure 45. Asia Pediatric CAR T-cell Therapy Market Share by Type (2021-2032) Figure 46. Asia Pediatric CAR T-cell Therapy Market Share by Application (2021-2032) Figure 47. Asia Pediatric CAR T-cell Therapy Market Share by Country (2021-2032) Figure 48. Japan Pediatric CAR T-cell Therapy Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Pediatric CAR T-cell Therapy Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Pediatric CAR T-cell Therapy Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Pediatric CAR T-cell Therapy Market Size (2021-2032) & (US$ Million) Figure 52. India Pediatric CAR T-cell Therapy Market Size (2021-2032) & (US$ Million) Figure 53. Australia Pediatric CAR T-cell Therapy Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Pediatric CAR T-cell Therapy Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Pediatric CAR T-cell Therapy Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Pediatric CAR T-cell Therapy Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Pediatric CAR T-cell Therapy Market Share by Country (2021-2032) Figure 58. Brazil Pediatric CAR T-cell Therapy Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Pediatric CAR T-cell Therapy Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Pediatric CAR T-cell Therapy Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Pediatric CAR T-cell Therapy Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Pediatric CAR T-cell Therapy Market Size (2021-2032) & (US$ Million) Figure 63. UAE Pediatric CAR T-cell Therapy Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Pediatric CAR T-cell Therapy Market Size (2021-2032) & (US$ Million) Figure 65. Chile Pediatric CAR T-cell Therapy Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • CD19
  • BCMA
  • Others
Applications
  • Multiple Myeloma
  • B-Cell Lymphoma (BCL)
  • Acute Lymphoblastic Leukemia (ALL)
  • Others
Companies covered
  • Bristol Myers Squibb，BMS
  • Johnson & Johnson
  • Gilead Sciences
  • Novartis
  • JW Therapeutics
  • Imunopharm Technology Co., Ltd.
  • CARsgen Therapeutics
  • Cartesian Therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Pediatric CAR T-cell Therapy Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 CD19
  5. 1.2.3 BCMA
  6. 1.2.4 Others
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Pediatric CAR T-cell Therapy Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Multiple Myeloma
  10. 1.3.3 B-Cell Lymphoma (BCL)
  11. 1.3.4 Acute Lymphoblastic Leukemia (ALL)
  12. 1.3.5 Others
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Pediatric CAR T-cell Therapy Growth Trends by Region
  15. 1.5.1 Global Pediatric CAR T-cell Therapy Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Pediatric CAR T-cell Therapy Market Size by Region (2021-2026)
  17. 1.5.3 Pediatric CAR T-cell Therapy Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Pediatric CAR T-cell Therapy Market Dynamics
  1. 2.1 Pediatric CAR T-cell Therapy Industry Trends
  2. 2.2 Pediatric CAR T-cell Therapy Industry Drivers
  3. 2.3 Pediatric CAR T-cell Therapy Industry Opportunities and Challenges
  4. 2.4 Pediatric CAR T-cell Therapy Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Pediatric CAR T-cell Therapy Revenue by Company (2021-2026)
  2. 3.2 Global Pediatric CAR T-cell Therapy Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Pediatric CAR T-cell Therapy Key Company Head office and Area Served
  4. 3.4 Global Pediatric CAR T-cell Therapy Company, Product Type & Application
  5. 3.5 Global Pediatric CAR T-cell Therapy Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Pediatric CAR T-cell Therapy Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Pediatric CAR T-cell Therapy Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Pediatric CAR T-cell Therapy Tier 1, Tier 2, and Tier 3
4 Pediatric CAR T-cell Therapy Market by Type
  1. 4.1 Global Pediatric CAR T-cell Therapy Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Pediatric CAR T-cell Therapy Market Size by Type (2021-2032)
  3. 4.3 Global Pediatric CAR T-cell Therapy Market Size Share by Type (2021-2032)
5 Pediatric CAR T-cell Therapy Market by Application
  1. 5.1 Global Pediatric CAR T-cell Therapy Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Pediatric CAR T-cell Therapy Market Size by Application (2021-2032)
  3. 5.3 Global Pediatric CAR T-cell Therapy Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Bristol Myers Squibb，BMS
  2. 6.1.1 Bristol Myers Squibb，BMS Company Information
  3. 6.1.2 Bristol Myers Squibb，BMS Business Overview
  4. 6.1.3 Bristol Myers Squibb，BMS Pediatric CAR T-cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Bristol Myers Squibb，BMS Pediatric CAR T-cell Therapy Product Portfolio
  6. 6.1.5 Bristol Myers Squibb，BMS Recent Developments
  7. 6.2 Johnson & Johnson
  8. 6.2.1 Johnson & Johnson Company Information
  9. 6.2.2 Johnson & Johnson Business Overview
  10. 6.2.3 Johnson & Johnson Pediatric CAR T-cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Johnson & Johnson Pediatric CAR T-cell Therapy Product Portfolio
  12. 6.2.5 Johnson & Johnson Recent Developments
  13. 6.3 Gilead Sciences
  14. 6.3.1 Gilead Sciences Company Information
  15. 6.3.2 Gilead Sciences Business Overview
  16. 6.3.3 Gilead Sciences Pediatric CAR T-cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Gilead Sciences Pediatric CAR T-cell Therapy Product Portfolio
  18. 6.3.5 Gilead Sciences Recent Developments
  19. 6.4 Novartis
  20. 6.4.1 Novartis Company Information
  21. 6.4.2 Novartis Business Overview
  22. 6.4.3 Novartis Pediatric CAR T-cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Novartis Pediatric CAR T-cell Therapy Product Portfolio
  24. 6.4.5 Novartis Recent Developments
  25. 6.5 JW Therapeutics
  26. 6.5.1 JW Therapeutics Company Information
  27. 6.5.2 JW Therapeutics Business Overview
  28. 6.5.3 JW Therapeutics Pediatric CAR T-cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 JW Therapeutics Pediatric CAR T-cell Therapy Product Portfolio
  30. 6.5.5 JW Therapeutics Recent Developments
  31. 6.6 Imunopharm Technology Co., Ltd.
  32. 6.6.1 Imunopharm Technology Co., Ltd. Company Information
  33. 6.6.2 Imunopharm Technology Co., Ltd. Business Overview
  34. 6.6.3 Imunopharm Technology Co., Ltd. Pediatric CAR T-cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Imunopharm Technology Co., Ltd. Pediatric CAR T-cell Therapy Product Portfolio
  36. 6.6.5 Imunopharm Technology Co., Ltd. Recent Developments
  37. 6.7 CARsgen Therapeutics
  38. 6.7.1 CARsgen Therapeutics Company Information
  39. 6.7.2 CARsgen Therapeutics Business Overview
  40. 6.7.3 CARsgen Therapeutics Pediatric CAR T-cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 CARsgen Therapeutics Pediatric CAR T-cell Therapy Product Portfolio
  42. 6.7.5 CARsgen Therapeutics Recent Developments
  43. 6.8 Cartesian Therapeutics
  44. 6.8.1 Cartesian Therapeutics Company Information
  45. 6.8.2 Cartesian Therapeutics Business Overview
  46. 6.8.3 Cartesian Therapeutics Pediatric CAR T-cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Cartesian Therapeutics Pediatric CAR T-cell Therapy Product Portfolio
  48. 6.8.5 Cartesian Therapeutics Recent Developments
7 North America
  1. 7.1 North America Pediatric CAR T-cell Therapy Market Size (2021-2032)
  2. 7.2 North America Pediatric CAR T-cell Therapy Market Size by Type
  3. 7.2.1 North America Pediatric CAR T-cell Therapy Market Size by Type (2021-2026)
  4. 7.2.2 North America Pediatric CAR T-cell Therapy Market Size by Type (2027-2032)
  5. 7.2.3 North America Pediatric CAR T-cell Therapy Market Share by Type (2021-2032)
  6. 7.3 North America Pediatric CAR T-cell Therapy Market Size by Application
  7. 7.3.1 North America Pediatric CAR T-cell Therapy Market Size by Application (2021-2026)
  8. 7.3.2 North America Pediatric CAR T-cell Therapy Market Size by Application (2027-2032)
  9. 7.3.3 North America Pediatric CAR T-cell Therapy Market Share by Application (2021-2032)
  10. 7.4 North America Pediatric CAR T-cell Therapy Market Size by Country
  11. 7.4.1 North America Pediatric CAR T-cell Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Pediatric CAR T-cell Therapy Market Size by Country (2021-2026)
  13. 7.4.3 North America Pediatric CAR T-cell Therapy Market Size by Country (2027-2032)
  14. 7.4.4 North America Pediatric CAR T-cell Therapy Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Pediatric CAR T-cell Therapy Market Size (2021-2032)
  2. 8.2 Europe Pediatric CAR T-cell Therapy Market Size by Type
  3. 8.2.1 Europe Pediatric CAR T-cell Therapy Market Size by Type (2021-2026)
  4. 8.2.2 Europe Pediatric CAR T-cell Therapy Market Size by Type (2027-2032)
  5. 8.2.3 Europe Pediatric CAR T-cell Therapy Market Share by Type (2021-2032)
  6. 8.3 Europe Pediatric CAR T-cell Therapy Market Size by Application
  7. 8.3.1 Europe Pediatric CAR T-cell Therapy Market Size by Application (2021-2026)
  8. 8.3.2 Europe Pediatric CAR T-cell Therapy Market Size by Application (2027-2032)
  9. 8.3.3 Europe Pediatric CAR T-cell Therapy Market Share by Application (2021-2032)
  10. 8.4 Europe Pediatric CAR T-cell Therapy Market Size by Country
  11. 8.4.1 Europe Pediatric CAR T-cell Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Pediatric CAR T-cell Therapy Market Size by Country (2021-2026)
  13. 8.4.3 Europe Pediatric CAR T-cell Therapy Market Size by Country (2027-2032)
  14. 8.4.4 Europe Pediatric CAR T-cell Therapy Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Pediatric CAR T-cell Therapy Market Size (2021-2032)
  2. 9.2 China Pediatric CAR T-cell Therapy Market Size by Type
  3. 9.2.1 China Pediatric CAR T-cell Therapy Market Size by Type (2021-2026)
  4. 9.2.2 China Pediatric CAR T-cell Therapy Market Size by Type (2027-2032)
  5. 9.2.3 China Pediatric CAR T-cell Therapy Market Share by Type (2021-2032)
  6. 9.3 China Pediatric CAR T-cell Therapy Market Size by Application
  7. 9.3.1 China Pediatric CAR T-cell Therapy Market Size by Application (2021-2026)
  8. 9.3.2 China Pediatric CAR T-cell Therapy Market Size by Application (2027-2032)
  9. 9.3.3 China Pediatric CAR T-cell Therapy Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Pediatric CAR T-cell Therapy Market Size (2021-2032)
  2. 10.2 Asia Pediatric CAR T-cell Therapy Market Size by Type
  3. 10.2.1 Asia Pediatric CAR T-cell Therapy Market Size by Type (2021-2026)
  4. 10.2.2 Asia Pediatric CAR T-cell Therapy Market Size by Type (2027-2032)
  5. 10.2.3 Asia Pediatric CAR T-cell Therapy Market Share by Type (2021-2032)
  6. 10.3 Asia Pediatric CAR T-cell Therapy Market Size by Application
  7. 10.3.1 Asia Pediatric CAR T-cell Therapy Market Size by Application (2021-2026)
  8. 10.3.2 Asia Pediatric CAR T-cell Therapy Market Size by Application (2027-2032)
  9. 10.3.3 Asia Pediatric CAR T-cell Therapy Market Share by Application (2021-2032)
  10. 10.4 Asia Pediatric CAR T-cell Therapy Market Size by Country
  11. 10.4.1 Asia Pediatric CAR T-cell Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Pediatric CAR T-cell Therapy Market Size by Country (2021-2026)
  13. 10.4.3 Asia Pediatric CAR T-cell Therapy Market Size by Country (2027-2032)
  14. 10.4.4 Asia Pediatric CAR T-cell Therapy Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Pediatric CAR T-cell Therapy Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Pediatric CAR T-cell Therapy Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Pediatric CAR T-cell Therapy Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Pediatric CAR T-cell Therapy Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Pediatric CAR T-cell Therapy Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Pediatric CAR T-cell Therapy Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Pediatric CAR T-cell Therapy Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Pediatric CAR T-cell Therapy Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Pediatric CAR T-cell Therapy Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Pediatric CAR T-cell Therapy Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Pediatric CAR T-cell Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Pediatric CAR T-cell Therapy Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Pediatric CAR T-cell Therapy Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Pediatric CAR T-cell Therapy Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst